Prevalence of Bacterial Coinfection and Patterns of Antibiotics Prescribing in Patients with COVID-19: A Systematic Review and Meta-analysis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Aug 1

PMID 35913964

Authors

Faisal Salman Alshaikh

Brian Godman

Oula Nawaf Sindi

R Andrew Seaton

Amanj Kurdi

Affiliations

Soon will be listed here.

Abstract

Background: Evidence around prevalence of bacterial coinfection and pattern of antibiotic use in COVID-19 is controversial although high prevalence rates of bacterial coinfection have been reported in previous similar global viral respiratory pandemics. Early data on the prevalence of antibiotic prescribing in COVID-19 indicates conflicting low and high prevalence of antibiotic prescribing which challenges antimicrobial stewardship programmes and increases risk of antimicrobial resistance (AMR).

Aim: To determine current prevalence of bacterial coinfection and antibiotic prescribing in COVID-19 patients.

Data Source: OVID MEDLINE, OVID EMBASE, Cochrane and MedRxiv between January 2020 and June 2021.

Study Eligibility: English language studies of laboratory-confirmed COVID-19 patients which reported (a) prevalence of bacterial coinfection and/or (b) prevalence of antibiotic prescribing with no restrictions to study designs or healthcare setting.

Participants: Adults (aged ≥ 18 years) with RT-PCR confirmed diagnosis of COVID-19, regardless of study setting.

Methods: Systematic review and meta-analysis. Proportion (prevalence) data was pooled using random effects meta-analysis approach; and stratified based on region and study design.

Results: A total of 1058 studies were screened, of which 22, hospital-based studies were eligible, compromising 76,176 of COVID-19 patients. Pooled estimates for the prevalence of bacterial co-infection and antibiotic use were 5.62% (95% CI 2.26-10.31) and 61.77% (CI 50.95-70.90), respectively. Sub-group analysis by region demonstrated that bacterial co-infection was more prevalent in North American studies (7.89%, 95% CI 3.30-14.18).

Conclusion: Prevalence of bacterial coinfection in COVID-19 is low, yet prevalence of antibiotic prescribing is high, indicating the need for targeted COVID-19 antimicrobial stewardship initiatives to reduce the global threat of AMR.

Citing Articles

Reducing blood culture contamination: an environmental imperative.

Gregg S, Purcell N, Doyle M, Chan G Access Microbiol. 2025; 7(2).

PMID: 40018270 PMC: 11865496. DOI: 10.1099/acmi.0.000897.v3.

Pathogenic and periodontal bacteria may contribute to the fatal outcome of critically ill elderly COVID-19 patients.

Madronero L, Calvo E, Coronel-Ruiz C, Velandia-Romero M, Calderon-Pelaez M, Arturo J Sci Rep. 2025; 15(1):4490.

PMID: 39915668 PMC: 11802917. DOI: 10.1038/s41598-025-88518-y.

Global trends in antibiotic consumption during 2016-2023 and future projections through 2030.

Klein E, Impalli I, Poleon S, Denoel P, Cipriano M, Van Boeckel T Proc Natl Acad Sci U S A. 2024; 121(49):e2411919121.

PMID: 39556760 PMC: 11626136. DOI: 10.1073/pnas.2411919121.

Impact of a hub-and-spoke approach to hospital antimicrobial stewardship programmes on antibiotic use in Zambia.

Kalungia A, Kampamba M, Banda D, Bambala A, Marshall S, Newport M JAC Antimicrob Resist. 2024; 6(6):dlae178.

PMID: 39502743 PMC: 11535659. DOI: 10.1093/jacamr/dlae178.

A quasi-experimental analysis comparing antimicrobial usage on COVID-19 and non-COVID-19 wards.

Doyle D, Dalton B, Zhang Z, Sabuda D, Rajakumar I, Rennert-May E Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e192.

PMID: 39483329 PMC: 11526180. DOI: 10.1017/ash.2024.417.

References

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

Founou R, Blocker A, Noubom M, Tsayem C, Choukem S, van Dongen M . The COVID-19 pandemic: a threat to antimicrobial resistance containment. Future Sci OA. 2021; 7(8):FSO736. PMC: 8204817. DOI: 10.2144/fsoa-2021-0012. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Cheng L, Chau S, Tso E, Tsang S, Li I, Wong B . Bacterial co-infections and antibiotic prescribing practice in adults with COVID-19: experience from a single hospital cluster. Ther Adv Infect Dis. 2020; 7:2049936120978095. PMC: 7724262. DOI: 10.1177/2049936120978095. View

Pulia M, Wolf I, Schwei R, Chen D, Lepak A, Schulz L . Antibiotic prescribing patterns for coronavirus disease 2019 (COVID-19) in two emergency departments with rapid procalcitonin. Infect Control Hosp Epidemiol. 2020; 42(3):359-361. PMC: 7737132. DOI: 10.1017/ice.2020.1329. View

Lansbury L, Lim B, Baskaran V, Lim W . Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020; 81(2):266-275. PMC: 7255350. DOI: 10.1016/j.jinf.2020.05.046. View

Huttner B, Catho G, Pano-Pardo J, Pulcini C, Schouten J . COVID-19: don't neglect antimicrobial stewardship principles!. Clin Microbiol Infect. 2020; 26(7):808-810. PMC: 7190532. DOI: 10.1016/j.cmi.2020.04.024. View

Nyaga V, Arbyn M, Aerts M . Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2015; 72(1):39. PMC: 4373114. DOI: 10.1186/2049-3258-72-39. View

Morris D, Cleary D, Clarke S . Secondary Bacterial Infections Associated with Influenza Pandemics. Front Microbiol. 2017; 8:1041. PMC: 5481322. DOI: 10.3389/fmicb.2017.01041. View

10.

Akpan M, Isemin N, Udoh A, Ashiru-Oredope D . Implementation of antimicrobial stewardship programmes in African countries: a systematic literature review. J Glob Antimicrob Resist. 2020; 22:317-324. DOI: 10.1016/j.jgar.2020.03.009. View

11.

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

12.

Vaughn V, Gandhi T, Petty L, Patel P, Prescott H, Malani A . Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study. Clin Infect Dis. 2020; 72(10):e533-e541. PMC: 7499526. DOI: 10.1093/cid/ciaa1239. View

13.

Deeks J, Macaskill P, Irwig L . The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005; 58(9):882-93. DOI: 10.1016/j.jclinepi.2005.01.016. View

14.

Molla M, Yeasmin M, Islam M, Sharif M, Amin M, Nafisa T . Antibiotic Prescribing Patterns at COVID-19 Dedicated Wards in Bangladesh: Findings from a Single Center Study. Infect Prev Pract. 2021; 3(2):100134. PMC: 7910658. DOI: 10.1016/j.infpip.2021.100134. View

15.

Grau S, Hernandez S, Echeverria-Esnal D, Almendral A, Ferrer R, Limon E . Antimicrobial Consumption among 66 Acute Care Hospitals in Catalonia: Impact of the COVID-19 Pandemic. Antibiotics (Basel). 2021; 10(8). PMC: 8388964. DOI: 10.3390/antibiotics10080943. View

16.

Mah-E-Muneer S, Hassan M, Biswas M, Rahman F, Akhtar Z, Das P . Use of Antimicrobials among Suspected COVID-19 Patients at Selected Hospitals, Bangladesh: Findings from the First Wave of COVID-19 Pandemic. Antibiotics (Basel). 2021; 10(6). PMC: 8235435. DOI: 10.3390/antibiotics10060738. View

17.

Godman B, Egwuenu A, Haque M, Malande O, Schellack N, Kumar S . Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries. Life (Basel). 2021; 11(6). PMC: 8229985. DOI: 10.3390/life11060528. View

18.

Puzniak L, Finelli L, Yu K, Bauer K, Moise P, De Anda C . A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19. BMC Infect Dis. 2021; 21(1):227. PMC: 7910773. DOI: 10.1186/s12879-021-05877-3. View

19.

Lardaro T, Wang A, Bucca A, Croft A, Glober N, Holt D . Characteristics of COVID-19 patients with bacterial coinfection admitted to the hospital from the emergency department in a large regional healthcare system. J Med Virol. 2021; 93(5):2883-2889. PMC: 8014736. DOI: 10.1002/jmv.26795. View

20.

Wang L, Amin A, Khanna P, Aali A, McGregor A, Bassett P . An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London. J Antimicrob Chemother. 2020; 76(3):796-803. PMC: 7717240. DOI: 10.1093/jac/dkaa475. View